Antenatal glucocorticoid treatment in the prevention of neonatal RDS
Antenatal glucocorticoid administration in order to prevent neonatal respiratory distress syndrome (RDS) has been an established regimen for over 15 years . Use of such therapy is indicated in all cases in which premature delivery is expected or medical reasons require it . Nevertheless, this treatment is only effective to a limited extent and, as before, a considerable number of premature children die of pulmonary complications. Therefore every obstetric unit has to re-evaluate the data in this particular field from time to time.
Unable to display preview. Download preview PDF.
- Liggins, G. C. and Howie, R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515.Google Scholar
- Papageorgiou, A. N., Colle, E., Farri-Kostopoulos, E. and Gelfand, M. M. Incidence of respiratory distress syndrome following antenatal betamethasone: role of sex, type of delivery and prolonged rupture of membranes. Pediatrics 1981; 67: 614–17.Google Scholar